Over Weight People Clinical Trial
Verified date | November 2020 |
Source | Shanghai Meiji Health Science and Technology Co., Ltd. |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Investigators performed a randomized double-blind trial to determine the effects of long-term NnEx ingestion in patients with overweight or obesity. Ninety-five participants (23<BMI<30 kg/m2) were randomly allocated to three groups: a control group, a 1 g/day NnEx group, and a 2 g/day NnEx group. The effects of the consumption of 2 g/day or 1 g/day NnEx for 12 weeks on indices of adiposity and fasting blood metabolic parameters were compared with those of no consumption of NnEx.
Status | Completed |
Enrollment | 95 |
Est. completion date | June 20, 2009 |
Est. primary completion date | May 15, 2009 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 40 Years to 60 Years |
Eligibility | Inclusion Criteria: - Has a body mass index (BMI) of 23-30 kg/m2 - Has no history of using any antidiabetic medication - Absence of liver, kidney, or heart disease - Absence of food allergy and daily tea consumption <2 L - Meet all of the above criteria and to follow the instructions given during the study. Exclusion Criteria: - Testing delayed for >1 week without justification - Difficulty attending the hospital on the required days - Lack of data regarding the times of beverage consumption for over 5% of the study - Abnormal overeating - Test results believed to be unreliable because of the lack of provision of diet and exercise reports during the fasting period - Difficulty drawing blood - Poor confidence in the test data |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Shanghai Meiji Health Science and Technology Co., Ltd. |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Changes in anthropometrix indices during the study | weight in kilograms | baseline, 6 weeks, 12 weeks | |
Primary | Changes in anthropometrix indices during the study | height in meters | baseline, 6 weeks, 12 weeks | |
Primary | Changes in anthropometrix indices during the study | body fat in percentage | baseline, 6 weeks, 12 weeks | |
Primary | Changes in anthropometrix indices during the study | visceral fat in percentage | baseline, 6 weeks, 12 weeks | |
Primary | Changes in anthropometrix indices during the study | waist in centimeters | baseline, 6 weeks, 12 weeks | |
Primary | Changes in anthropometrix indices during the study | hip in centimeters | baseline, 6 weeks, 12 weeks | |
Secondary | Changes in fasting biochemical indices during the study | glucose in mmol/L | baseline, 6 weeks, 12 weeks | |
Secondary | Changes in fasting biochemical indices during the study | HbA1c in mmol/L | baseline, 6 weeks, 12 weeks | |
Secondary | Changes in fasting biochemical indices during the study | TG in mmol/L | baseline, 6 weeks, 12 weeks | |
Secondary | Changes in fasting biochemical indices during the study | FFA in mmol/L | baseline, 6 weeks, 12 weeks | |
Secondary | Changes in fasting biochemical indices during the study | T-cho in mmol/L | baseline, 6 weeks, 12 weeks | |
Secondary | Changes in fasting biochemical indices during the study | HDL-cho in mmol/L | baseline, 6 weeks, 12 weeks | |
Secondary | Changes in fasting biochemical indices during the study | LDL-cho in mmol/L | baseline, 6 weeks, 12 weeks | |
Secondary | Changes in fasting biochemical indices during the study | ASP in mmol/L | baseline, 6 weeks, 12 weeks | |
Secondary | Changes in fasting biochemical indices during the study | BUN in mmol/L | baseline, 6 weeks, 12 weeks |